Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Sell
27
DHT.UN.TO Quote, Financials, Valuation and Earnings
Last price:
$16.15
Seasonality move
:
0.02%
Day range:
$16.14 - $16.30
52-week range:
$10.70 - $17.31
Dividend yield:
3.37%
P/E ratio:
158.20x
P/S ratio:
3.34x
P/B ratio:
1.46x
Volume:
39.6K
Avg. volume:
36.6K
1-year change:
33.17%
Market cap:
$889.8M
Revenue:
$256.2M
EPS (TTM):
-$1.30
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
DHT.UN.TO
DRI Healthcare Trust
|
-- | -- | -- | -- | -- |
|
COOL.CX
Core One Labs, Inc.
|
-- | -- | -- | -- | -- |
|
CURE.X.CX
Biocure Technology
|
-- | -- | -- | -- | -- |
|
HEAL.CX
|
-- | -- | -- | -- | -- |
|
NSHS.CX
NanoSphere Health Sciences, Inc.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
DHT.UN.TO
DRI Healthcare Trust
|
$16.15 | -- | $889.8M | 158.20x | $0.14 | 3.37% | 3.34x |
|
COOL.CX
Core One Labs, Inc.
|
$0.15 | -- | $6.8M | -- | $0.00 | 0% | 32.71x |
|
CURE.X.CX
Biocure Technology
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
HEAL.CX
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
NSHS.CX
NanoSphere Health Sciences, Inc.
|
$0.0250 | -- | $256.9K | 0.65x | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
DHT.UN.TO
DRI Healthcare Trust
|
50.77% | 1.252 | 78.32% | 0.45x |
|
COOL.CX
Core One Labs, Inc.
|
-- | 0.000 | -- | -- |
|
CURE.X.CX
Biocure Technology
|
-- | 0.000 | -- | -- |
|
HEAL.CX
|
-- | 0.000 | -- | -- |
|
NSHS.CX
NanoSphere Health Sciences, Inc.
|
-3.43% | 1.456 | 20.53% | 0.00x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
DHT.UN.TO
DRI Healthcare Trust
|
$27.9M | $19.1M | -5.59% | -10.24% | 29.37% | -$56.5M |
|
COOL.CX
Core One Labs, Inc.
|
-- | -- | -- | -- | -- | -- |
|
CURE.X.CX
Biocure Technology
|
-- | -- | -- | -- | -- | -- |
|
HEAL.CX
|
-- | -- | -- | -- | -- | -- |
|
NSHS.CX
NanoSphere Health Sciences, Inc.
|
-- | -$72.1K | -- | -- | -- | -$92.1K |
DRI Healthcare Trust vs. Competitors
-
Which has Higher Returns DHT.UN.TO or COOL.CX?
Core One Labs, Inc. has a net margin of -122.75% compared to DRI Healthcare Trust's net margin of --. DRI Healthcare Trust's return on equity of -10.24% beat Core One Labs, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital DHT.UN.TODRI Healthcare Trust42.98% -$1.44 $1.2B COOL.CXCore One Labs, Inc.-- -- -- -
What do Analysts Say About DHT.UN.TO or COOL.CX?
DRI Healthcare Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand Core One Labs, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that DRI Healthcare Trust has higher upside potential than Core One Labs, Inc., analysts believe DRI Healthcare Trust is more attractive than Core One Labs, Inc..
Company Buy Ratings Hold Ratings Sell Ratings DHT.UN.TODRI Healthcare Trust0 0 0 COOL.CXCore One Labs, Inc.0 0 0 -
Is DHT.UN.TO or COOL.CX More Risky?
DRI Healthcare Trust has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Core One Labs, Inc. has a beta of 0.495, suggesting its less volatile than the S&P 500 by 50.458%.
-
Which is a Better Dividend Stock DHT.UN.TO or COOL.CX?
DRI Healthcare Trust has a quarterly dividend of $0.14 per share corresponding to a yield of 3.37%. Core One Labs, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. DRI Healthcare Trust pays 998.74% of its earnings as a dividend. Core One Labs, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios DHT.UN.TO or COOL.CX?
DRI Healthcare Trust quarterly revenues are $64.9M, which are larger than Core One Labs, Inc. quarterly revenues of --. DRI Healthcare Trust's net income of -$79.7M is higher than Core One Labs, Inc.'s net income of --. Notably, DRI Healthcare Trust's price-to-earnings ratio is 158.20x while Core One Labs, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for DRI Healthcare Trust is 3.34x versus 32.71x for Core One Labs, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DHT.UN.TODRI Healthcare Trust3.34x 158.20x $64.9M -$79.7M COOL.CXCore One Labs, Inc.32.71x -- -- --
-
Which has Higher Returns DHT.UN.TO or CURE.X.CX?
Biocure Technology has a net margin of -122.75% compared to DRI Healthcare Trust's net margin of --. DRI Healthcare Trust's return on equity of -10.24% beat Biocure Technology's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital DHT.UN.TODRI Healthcare Trust42.98% -$1.44 $1.2B CURE.X.CXBiocure Technology-- -- -- -
What do Analysts Say About DHT.UN.TO or CURE.X.CX?
DRI Healthcare Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand Biocure Technology has an analysts' consensus of -- which suggests that it could fall by --. Given that DRI Healthcare Trust has higher upside potential than Biocure Technology, analysts believe DRI Healthcare Trust is more attractive than Biocure Technology.
Company Buy Ratings Hold Ratings Sell Ratings DHT.UN.TODRI Healthcare Trust0 0 0 CURE.X.CXBiocure Technology0 0 0 -
Is DHT.UN.TO or CURE.X.CX More Risky?
DRI Healthcare Trust has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Biocure Technology has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock DHT.UN.TO or CURE.X.CX?
DRI Healthcare Trust has a quarterly dividend of $0.14 per share corresponding to a yield of 3.37%. Biocure Technology offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. DRI Healthcare Trust pays 998.74% of its earnings as a dividend. Biocure Technology pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios DHT.UN.TO or CURE.X.CX?
DRI Healthcare Trust quarterly revenues are $64.9M, which are larger than Biocure Technology quarterly revenues of --. DRI Healthcare Trust's net income of -$79.7M is higher than Biocure Technology's net income of --. Notably, DRI Healthcare Trust's price-to-earnings ratio is 158.20x while Biocure Technology's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for DRI Healthcare Trust is 3.34x versus -- for Biocure Technology. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DHT.UN.TODRI Healthcare Trust3.34x 158.20x $64.9M -$79.7M CURE.X.CXBiocure Technology-- -- -- --
-
Which has Higher Returns DHT.UN.TO or HEAL.CX?
has a net margin of -122.75% compared to DRI Healthcare Trust's net margin of --. DRI Healthcare Trust's return on equity of -10.24% beat 's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital DHT.UN.TODRI Healthcare Trust42.98% -$1.44 $1.2B HEAL.CX-- -- -- -
What do Analysts Say About DHT.UN.TO or HEAL.CX?
DRI Healthcare Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand has an analysts' consensus of -- which suggests that it could fall by --. Given that DRI Healthcare Trust has higher upside potential than , analysts believe DRI Healthcare Trust is more attractive than .
Company Buy Ratings Hold Ratings Sell Ratings DHT.UN.TODRI Healthcare Trust0 0 0 HEAL.CX0 0 0 -
Is DHT.UN.TO or HEAL.CX More Risky?
DRI Healthcare Trust has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock DHT.UN.TO or HEAL.CX?
DRI Healthcare Trust has a quarterly dividend of $0.14 per share corresponding to a yield of 3.37%. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. DRI Healthcare Trust pays 998.74% of its earnings as a dividend. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios DHT.UN.TO or HEAL.CX?
DRI Healthcare Trust quarterly revenues are $64.9M, which are larger than quarterly revenues of --. DRI Healthcare Trust's net income of -$79.7M is higher than 's net income of --. Notably, DRI Healthcare Trust's price-to-earnings ratio is 158.20x while 's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for DRI Healthcare Trust is 3.34x versus -- for . Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DHT.UN.TODRI Healthcare Trust3.34x 158.20x $64.9M -$79.7M HEAL.CX-- -- -- --
-
Which has Higher Returns DHT.UN.TO or NSHS.CX?
NanoSphere Health Sciences, Inc. has a net margin of -122.75% compared to DRI Healthcare Trust's net margin of --. DRI Healthcare Trust's return on equity of -10.24% beat NanoSphere Health Sciences, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital DHT.UN.TODRI Healthcare Trust42.98% -$1.44 $1.2B NSHS.CXNanoSphere Health Sciences, Inc.-- -$0.00 -$1.8M -
What do Analysts Say About DHT.UN.TO or NSHS.CX?
DRI Healthcare Trust has a consensus price target of --, signalling downside risk potential of --. On the other hand NanoSphere Health Sciences, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that DRI Healthcare Trust has higher upside potential than NanoSphere Health Sciences, Inc., analysts believe DRI Healthcare Trust is more attractive than NanoSphere Health Sciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings DHT.UN.TODRI Healthcare Trust0 0 0 NSHS.CXNanoSphere Health Sciences, Inc.0 0 0 -
Is DHT.UN.TO or NSHS.CX More Risky?
DRI Healthcare Trust has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison NanoSphere Health Sciences, Inc. has a beta of 0.627, suggesting its less volatile than the S&P 500 by 37.292%.
-
Which is a Better Dividend Stock DHT.UN.TO or NSHS.CX?
DRI Healthcare Trust has a quarterly dividend of $0.14 per share corresponding to a yield of 3.37%. NanoSphere Health Sciences, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. DRI Healthcare Trust pays 998.74% of its earnings as a dividend. NanoSphere Health Sciences, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios DHT.UN.TO or NSHS.CX?
DRI Healthcare Trust quarterly revenues are $64.9M, which are larger than NanoSphere Health Sciences, Inc. quarterly revenues of --. DRI Healthcare Trust's net income of -$79.7M is lower than NanoSphere Health Sciences, Inc.'s net income of -$13.1K. Notably, DRI Healthcare Trust's price-to-earnings ratio is 158.20x while NanoSphere Health Sciences, Inc.'s PE ratio is 0.65x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for DRI Healthcare Trust is 3.34x versus -- for NanoSphere Health Sciences, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DHT.UN.TODRI Healthcare Trust3.34x 158.20x $64.9M -$79.7M NSHS.CXNanoSphere Health Sciences, Inc.-- 0.65x -- -$13.1K
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Buy
60
ZBIO alert for Dec 24
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
Buy
54
UNF alert for Dec 24
UniFirst Corp. [UNF] is up 0.77% over the past day.
